Dem senators ask drug companies to list prices in ads

Dem senators ask drug companies to list prices in ads
© Getty Images

A group of mostly Democratic senators is urging eight major drug companies to include the price of their drugs in advertisements, a measure that President TrumpDonald John TrumpAlaska Republican Party cancels 2020 primary Ukrainian official denies Trump pressured president Trump goes after New York Times, Washington Post: 'They have gone totally CRAZY!!!!' MORE endorsed last week in his drug-pricing blueprint.

“We are pleased that the President recently acknowledged the importance of requiring price disclosure on direct-to-consumer ads—it is our hope that he will actually follow through,” Sens. Dick DurbinRichard (Dick) Joseph DurbinOvernight Health Care — Presented by Partnership for America's Health Care Future — Walmart to stop selling e-cigarettes | Senators press FDA to pull most e-cigarettes immediately | House panel tees up e-cig hearing for next week Hillicon Valley: Lawmakers say Zuckerberg to 'cooperate' on antitrust probes | Dems see victory after McConnell backs election security funds | Twitter takes down fake pro-Saudi accounts Bipartisan group of senators urges FDA to pull most e-cigarettes immediately MORE (D-Ill.), Kirsten GillibrandKirsten GillibrandBooker aide sounds alarm about campaign's funding O'Rourke gun confiscation talk alarms Democrats Gillibrand relaunches PAC to elect women MORE (D-N.Y.), Maggie HassanMargaret (Maggie) HassanDemocrats hit Scalia over LGBTQ rights Overnight Health Care: Juul's lobbying efforts fall short as Trump moves to ban flavored e-cigarettes | Facebook removes fact check from anti-abortion video after criticism | Poll: Most Democrats want presidential candidate who would build on ObamaCare Lawmakers weigh responses to rash of ransomware attacks MORE (D-N.H.), Sherrod BrownSherrod Campbell BrownBipartisan housing finance reform on the road less taken Hillicon Valley: Google to promote original reporting | Senators demand answers from Amazon on worker treatment | Lawmakers weigh response to ransomware attacks Senate Democrats want answers on 'dangerous' Amazon delivery system MORE (D-Ohio) and Angus KingAngus Stanley KingOvernight Defense: Dems grill Trump Army, Air Force picks | House chair subpoenas Trump Afghanistan negotiator | Trump officials release military aid to Ukraine Democrats grill Army, Air Force nominees on military funding for border wall Bipartisan panel to issue recommendations for defending US against cyberattacks early next year MORE (I-Maine) wrote to the drug companies.

“As an honest first step to the American public, we urge you to immediately and voluntarily commit to transparency and disclose the price of your prescription drugs in direct-to-consumer advertisements,” the letter sent Friday states.

ADVERTISEMENT

The letter was sent to major pharmaceutical companies such as Eli Lilly, Novartis and Pfizer. 

Trump released a plan last week directing the Food and Drug Administration to study the possibility of including the list prices of drugs in direct-to-consumer advertising. The measure was part of Trump's blueprint aimed at lowering prescription drug costs.

Durbin introduced a bill last year that would require a similar disclosure of drug prices.

While pharmaceutical companies have to include warnings and side effects for drugs in television advertisements, they currently do not have to include prices.

Some have voiced concerns that including the list price of drugs could confuse consumers or deter them from purchasing the product, since the price at a pharmacy is often much lower if the individual has health insurance.

At an event with reporters Tuesday, Lori Reilly, an executive vice president of the Pharmaceutical Research and Manufacturers of America (PhRMA), discussed the issue of forcing companies to include the price of drugs in ads, arguing "it’s an open question about whether or not it’s constitutional.”

This post was updated at 4 p.m.